《外圍股市》觀望稍後通脹數據 美股期貨全面微吐
亞太股市今天個別發展,澳洲200及菲股分別續升近1.2%及彈近1.9%外,其餘升跌均少於0.7%,其中印尼反彈0.6%,深成反覆回升0.2%,滬指及日經反覆靠穩。相反,印度及新加坡跌0.4%;港股在科指倒跌1.8%及藍籌內房疲弱等拖累,由今早曾續升262點或1.2%至21,698創半年高,掉頭低見21,223,現報21,426,倒跌9點。藍籌股以阿里(09988.HK)、李寧(02331.HK)、藥明生物(02269.HK)、騰訊(00700.HK)、龍湖(00960.HK)及碧服(06098.HK)沽壓最大,股價反覆跌2.5%-6%。
市場觀望美國稍後出爐通脹數據,美股三大指數繼昨晚全面高收續升0.8%-1.8%後,期貨全面回軟,道指期貨報34,076,回吐34點或0.1%;標普五百期貨及已四連漲的納指一百期貨報3,986及11,454,回吐0.1%及0.2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.